Otezla 30 MG tab 60S
Ended Awarded
- Contract number
- SPE2DR26FAQVX
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $33,840
Award facts
- Contract value 100% obligated
- $33,840.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $33,840.25 to AmerisourceBergen Drug Corp for the supply of Otezla 30 mg tablets (60-count units) on October 23, 2025, with an ultimate completion date of November 20, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), a $999.99 billion prime vendor agreement running through December 2026 that provides comprehensive pharmaceutical and medical supply support to military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, supplies a broad range of pharmaceuticals, vaccines, medical devices, and specialized healthcare commodities to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order for Otezla, a branded psoriatic arthritis medication, exemplifies the company's role in fulfilling military and federal healthcare pharmaceutical needs through the DLA's global pharmaceutical support vehicle. As the Defense Logistics Agency continues to plan generation five contracts for its Pharmaceutical Prime Vendor Global Program with multiple regional awards anticipated, AmerisourceBergen maintains a significant presence within this strategic medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DR26FAQVX?
SPE2DR26FAQVX was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 23, 2025.
How much is contract SPE2DR26FAQVX worth?
The government has obligated $33,840 on SPE2DR26FAQVX.
Is contract SPE2DR26FAQVX an order under another contract?
Yes. SPE2DR26FAQVX is a delivery order under SPE2DR25D6028, an indefinite delivery contract.
Was contract SPE2DR26FAQVX competed?
The extent of competition for SPE2DR26FAQVX was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award